Tomas Kiselak, Director: Apogee Therapeutics APGE Sell · Filed 01/22

Trade details

Type: Insider sale
Amount: $133,525,000
Shares · price: 1,750,000 sh · $76.30 a share
Held after: 298,647 sh
Stock: Apogee Therapeutics APGE
Person: Tomas KiselakDirector
Trade date: 26/01/22
Filed: 26/01/22
Days to filing: 0 days

Sold 85.4% of holdings

Share of holding sold: 85.4%

Apogee Therapeutics trades, last 26 weeks

What else happened in Apogee Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/23~02/21

Tomas Kiselak's recent trades

Tomas KiselakDirector
SellSpyre Therapeutics
Sell
Spyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
Tomas KiselakDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31
Tomas KiselakDirector
BuyCrescent Biopharma
Buy
Crescent Biopharma
CBIO
$18.2M
1,360,000 sh
$18.2M
Filed 25/12/08
Traded 25/12/04
Tomas KiselakDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$6M
316,219 sh
$6M
Filed 25/10/09
Traded 25/10/07
Tomas KiselakDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$5.1M
300,000 sh
$5.1M
Filed 24/09/17
Traded 24/09/16